4//SEC Filing
Appelhans Dannielle 4
Accession 0001104659-23-009464
CIK 0001709401other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 9:40 PM ET
Size
15.9 KB
Accession
0001104659-23-009464
Insider Transaction Report
Form 4
Appelhans Dannielle
Chief Operating Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-01-31−7,500→ 22,500 total→ Common Stock (7,500 underlying) - Sale
Common Stock
2023-02-01$0.25/sh−3,878$970→ 10,385 total - Exercise/Conversion
Common Stock
2023-01-31+7,500→ 14,263 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the reporting person.
- [F3]The shares underlying the restricted stock units vest in four equal annual installments beginning on January 31, 2023.
Issuer
Rubius Therapeutics, Inc.
CIK 0001709401
Entity typeother
Related Parties
1- filerCIK 0001874962
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 9:40 PM ET
- Size
- 15.9 KB